Treating critical illness: the importance of first doing no harm.
Singer
Mervyn
M
Bloomsbury Institute of Intensive Care Medicine, University College London, United Kingdom. m.singer@ucl.ac.uk
Glynne
Paul
P
D000671:Amputation, Surgical / Q000266:history / Q000401:mortality; D002303:Cardiac Output, Low / Q000401:mortality / Q000628:therapy; D003422:Critical Care / Q000379:methods; D016638:Critical Illness / Q000401:mortality / Q000628:therapy*; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D019317:Evidence-Based Medicine; D049672:History, 19th Century; D006801:Humans; D008928:Mitochondria / Q000187:drug effects; D012121:Respiration, Artificial / Q000009:adverse effects; D018805:Sepsis / Q000401:mortality / Q000628:therapy; D065227:Transfusion Reaction